Sinopharm
1099.HK
$2.29
Share price
0.91%
Change (1 day)
-14.61%
Change (1 year)
Categories
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.
Revenue for Sinopharm (1099.HK)
Revenue in 2023 (TTM): $61.71 Billion USD
According to Sinopharm's latest financial reports the company's current revenue (TTM 
) is $84.39 Billion USD. an increase over the revenue in the year 2022 that were of $80.05 Billion USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Sinopharm from 2006 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 | $84.39 B | 5.42% |
| 2022 | $80.05 B | -2.1% |
| 2021 | $81.77 B | 16.85% |
| 2020 | $69.97 B | 14.95% |
| 2019 | $60.87 B | 21.52% |
| 2018 | $50.09 B | 5.93% |
| 2017 | $47.29 B | 27.22% |
| 2016 | $37.17 B | 5.37% |
| 2015 | $35.27 B | 9.14% |
| 2014 | $32.32 B | 17.22% |
| 2013 | $27.57 B | 25.94% |
| 2012 | $21.89 B | 34.61% |
| 2011 | $16.26 B | 55.34% |
| 2010 | $10.47 B | 35.79% |
| 2009 | $7.71 B | 37.56% |
| 2008 | $5.60 B | 31.43% |
| 2007 | $4.26 B | 40.26% |
| 2006 | $3.04 B |